Projects

TES Pharma discovers and develops small molecule therapeutics in partnership with key industry and academic leaders, our partnered projects are taking forward a range of novel compounds that open new approaches for metabolic diseases and oncology:

METABOLIC DISEASES

Intercept Pharmaceuticals,
New York
Strategic alliance exploring novel bile acid therapeutic space.
École Polytechnique Fédérale de Lausanne (EPFL),
Switzerland

Laboratory of Integrative Systems Physiology
Collaboration with Prof. Johan Auwerx to develop modulators for novel approaches to the treatment of metabolic disorders.

 

ONCOLOGY

Rasna Therapeutics,
London
TES Pharma is a co-founder of RASNA Therapeutics for development of novel small molecules, for the treatment of leukemia, lymphoma and other cancers.